Patent · US Active

Methods for treating Barrett's metaplasia and esophageal adenocarcinoma

US10255410B2 · kind B2 · utility

0Cited by
3References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 3, 2012
Grant dateApr 9, 2019
Priority date
Expiry dateJan 23, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B18/12
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Disclosed herein are methods for treating Barrett's metaplasia and esophageal adenocarcinoma and methods for determining mutational load as a predictor of the risk of disease progression from Barrett's metaplasia to esophageal adenocarcinoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.